# FDA recall D-0565-2025

> **AEQUITA PHARMACY** · Class II · drug recall initiated 2025-07-18.

## Product

Semaglutide + Cyanocobalamin 2.67 mg + 0.25mg/0.5 mL Inj Sol, Inject 0.5 mL (50 units on syringe) subcutaneously, Sterile, 2 mL Multi Dose Vial, Refrigerate, Do not freeze, Aequita Pharmacy LLC, Kirkland, WA 98034.

## Reason for recall

Lack of Processing Controls.

## Distribution

MA

## Key facts

- **Recall number:** D-0565-2025
- **Recalling firm:** AEQUITA PHARMACY
- **Classification:** Class II
- **Product type:** drug
- **Status:** Ongoing
- **Initiation date:** 2025-07-18
- **Report date:** 2025-08-13

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Kirkland, WA, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0565-2025

## Citation

> AI Analytics. FDA recall D-0565-2025. Retrieved 2026-06-25 from https://api.ai-analytics.org/recall/D-0565-2025. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*